目次

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Pharma Wholesale and Distribution Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Global Pharmaceutical Sales
3.2.1.2 Increasing Government Initiatives for Pharmaceutical Products
3.2.1.3 Rising Seaborne Pharmaceutical Transportation
3.2.1.4 Technological Advancements in Pharmaceutical Distribution
3.2.1.5 Implementation of Track and Trace Solutions
3.2.2 Market Restraining Factors
3.2.2.1 Stringent Regulations Imposed by Government
3.2.2.2 Price Pressures Likely to Challenge Market Growth
3.2.2.3 Rise in Pharmaceutical Counterfeiting
3.2.3 Market Opportunities
3.2.3.1 Specializing in Niche Drugs and Therapies
3.2.3.2 Embracing E-commerce and Digital Technologies
3.2.3.3 Focusing on Sustainability and Ethical Sourcing
3.2.3.4 Implementation of AI in Pharmaceutical Supply Chain
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Pharma Wholesale and Distribution Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
4.4 Wholesalers
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.4.3 Producer Wholesaler
4.4.3.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.3.2 Market Share by Region, 2024 & 2034 (%)
4.4.4 Merchant Wholesaler
4.4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.4.2 Market Share by Region, 2024 & 2034 (%)
4.4.5 Agents and Brokers
4.4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.5.2 Market Share by Region, 2024 & 2034 (%)
4.5 Distributor
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.5.3 Single Party Distributor
4.5.3.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.3.2 Market Share by Region, 2024 & 2034 (%)
4.5.4 Multi Party Distributor
4.5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.4.2 Market Share by Region, 2024 & 2034 (%)

5 Pharma Wholesale and Distribution Market Analysis by Distribution Type
5.1 Key Findings
5.2 Distribution Type Segment: Market Attractiveness Index
5.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
5.4 Ethical/Branded Pharma Products Distributors
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Generic Pharma Products Distributors
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Propaganda Cum Distribution (PCD) Franchise
5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 OTC/Institutional Supply Pharma Distributors
5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Others
5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Pharma Wholesale and Distribution Market Analysis by Product Type
6.1 Key Findings
6.2 Product Type Segment: Market Attractiveness Index
6.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
6.4 Branded Pharmaceuticals
6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Generic Pharmaceuticals
6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Over-the-counter (OTC) Pharmaceuticals
6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Medical Devices
6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Vaccines
6.8.1 Market Size by Region, 2024-2034 (US$ Billion)
6.8.2 Market Share by Region, 2024 & 2034 (%)
6.9 Others
6.9.1 Market Size by Region, 2024-2034 (US$ Billion)
6.9.2 Market Share by Region, 2024 & 2034 (%)

7 Pharma Wholesale and Distribution Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast

8 North America Pharma Wholesale and Distribution Market Analysis
8.1 Key Findings
8.2 North America Pharma Wholesale and Distribution Market Attractiveness Index
8.3 North America Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
8.4 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
8.5 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
8.6 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
8.7 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
8.8 U.S. Pharma Wholesale and Distribution Market Analysis
8.9 Canada Pharma Wholesale and Distribution Market Analysis

9 Europe Pharma Wholesale and Distribution Market Analysis
9.1 Key Findings
9.2 Europe Pharma Wholesale and Distribution Market Attractiveness Index
9.3 Europe Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
9.5 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
9.6 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
9.7 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
9.8 Germany Pharma Wholesale and Distribution Market Analysis
9.9 France Pharma Wholesale and Distribution Market Analysis
9.10 UK Pharma Wholesale and Distribution Market Analysis
9.11 Italy Pharma Wholesale and Distribution Market Analysis
9.12 Spain Pharma Wholesale and Distribution Market Analysis
9.13 Russia Pharma Wholesale and Distribution Market Analysis
9.14 Rest of Europe Pharma Wholesale and Distribution Market Analysis

10 Asia Pacific Pharma Wholesale and Distribution Market Analysis
10.1 Key Findings
10.2 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
10.3 Asia Pacific Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
10.5 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
10.6 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
10.7 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
10.8 Japan Pharma Wholesale and Distribution Market Analysis
10.9 China Pharma Wholesale and Distribution Market Analysis
10.10 India Pharma Wholesale and Distribution Market Analysis
10.11 Australia Pharma Wholesale and Distribution Market Analysis
10.12 South Korea Pharma Wholesale and Distribution Market Analysis
10.13 Singapore Pharma Wholesale and Distribution Market Analysis
10.14 Rest of Asia Pacific Pharma Wholesale and Distribution Market Analysis

11 Latin America Pharma Wholesale and Distribution Market Analysis
11.1 Key Findings
11.2 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
11.3 Latin America Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
11.5 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
11.6 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
11.7 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
11.8 Brazil Pharma Wholesale and Distribution Market Analysis
11.9 Mexico Pharma Wholesale and Distribution Market Analysis
11.10 Argentina Pharma Wholesale and Distribution Market Analysis
11.11 Colombia Pharma Wholesale and Distribution Market Analysis
11.12 Rest of Latin America Pharma Wholesale and Distribution Market Analysis

12 MEA Pharma Wholesale and Distribution Market Analysis
12.1 Key Findings
12.2 MEA Pharma Wholesale and Distribution Market Attractiveness Index
12.3 MEA Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
12.4 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
12.5 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
12.6 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
12.7 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
12.8 GCC Pharma Wholesale and Distribution Market Analysis
12.9 South Africa Pharma Wholesale and Distribution Market Analysis
12.10 Rest of MEA Pharma Wholesale and Distribution Market Analysis

13 Company Profiles
13.1 Competitive Landscape, 2022
13.2 Strategic Outlook
13.3 AmerisourceBergen Corporation
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2022
13.3.3.2 Regional Market Shares, 2022
13.3.4 Service Benchmarking
13.3.5 Strategic Outlook
13.4 Cardinal Health, Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2022
13.4.3.2 Regional Market Shares, 2022
13.4.4 Service Benchmarking
13.4.5 Strategic Outlook
13.5 CuraScript, Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Service Benchmarking
13.6 Dakota Drug, Inc.
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Service Benchmarking
13.7 Fortissa
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Service Benchmarking
13.8 Geo-Young Co., Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Service Benchmarking
13.9 Kingworld Medicines Group Limited
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Service Benchmarking
13.10 Mckesson Corporation
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2017-2022
13.10.3.2 Regional Market Shares, 2022
13.10.4 Service Benchmarking
13.10.5 Strategic Outlook
13.11 Medipal Holdings Corporation
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2017-2022
13.11.4 Service Benchmarking
13.11.5 Strategic Outlook
13.12 Mutual Drug
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Service Benchmarking
13.13 Petrone Group
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Service Benchmarking
13.13.4 Strategic Outlook
13.14 Prodigy Health LLC
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Service Benchmarking
13.15 Sinopharm Group Co. Ltd.
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2017-2022
13.15.4 Service Benchmarking
13.15.5 Strategic Outlook
13.16 Smith Drug Co., Inc.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Service Benchmarking
13.17 Walgreens Boots Alliance, Inc.
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2017-2022
13.17.4 Service Benchmarking
13.17.5 Strategic Outlook

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players

List of Tables
Table 1 Pharma Wholesale and Distribution Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Pharma Wholesale and Distribution Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Pharma Wholesale and Distribution Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Pharma Wholesale and Distribution Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Pharma Wholesale and Distribution Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 7 Wholesalers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 8 Producer Wholesaler Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 9 Merchant Wholesaler Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Agents and Brokers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Single Party Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Multi Party Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Ethical/Branded Pharma Products Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 16 Generic Pharma Products Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 17 Propaganda Cum Distribution (PCD) Franchise Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 18 OTC/Institutional Supply Pharma Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Branded Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Generic Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Over-the-counter (OTC) Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Medical Devices Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Vaccines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 Pharma Wholesale and Distribution Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 28 North America Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 29 North America Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 North America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 32 U.S. Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Canada Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 34 Europe Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 35 Europe Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 36 Europe Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 37 Europe Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 Germany Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 France Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 UK Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Italy Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Spain Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Russia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 44 Rest of Europe Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 47 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 48 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 Japan Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 50 China Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 51 India Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Australia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 South Korea Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Singapore Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Rest of Asia Pacific Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Latin America Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 57 Latin America Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 58 Latin America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 59 Latin America Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Brazil Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 Mexico Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 Argentina Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 63 Colombia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 Rest of Latin America Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 65 MEA Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 66 MEA Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 MEA Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 MEA Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 69 GCC Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 70 South Africa Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 71 Rest of MEA Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 72 Strategic Outlook
Table 73 AmerisourceBergen Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 AmerisourceBergen Corporation: Service Benchmarking
Table 75 AmerisourceBergen Corporation: Strategic Outlook
Table 76 Cardinal Health, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Cardinal Health, Inc.: Service Benchmarking
Table 78 Cardinal Health, Inc.: Strategic Outlook
Table 79 CuraScript, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 CuraScript, Inc.: Service Benchmarking
Table 81 Dakota Drug, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Dakota Drug, Inc.: Service Benchmarking
Table 83 Fortissa: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Fortissa: Service Benchmarking
Table 85 Geo-Young Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Geo-Young Co., Ltd.: Service Benchmarking
Table 87 Kingworld Medicines Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Kingworld Medicines Group Limited: Service Benchmarking
Table 89 Mckesson Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Mckesson Corporation: Service Benchmarking
Table 91 Mckesson Corporation: Strategic Outlook
Table 92 Medipal Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Medipal Holdings Corporation: Service Benchmarking
Table 94 Medipal Holdings Corporation: Strategic Outlook
Table 95 Mutual Drug: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Mutual Drug: Service Benchmarking
Table 97 Petrone Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Petrone Group: Service Benchmarking
Table 99 Petrone Group: Strategic Outlook
Table 100 Prodigy Health LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Prodigy Health LLC: Service Benchmarking
Table 102 Sinopharm Group Co. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Sinopharm Group Co. Ltd.: Service Benchmarking
Table 104 Sinopharm Group Co. Ltd.: Strategic Outlook
Table 105 Smith Drug Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Smith Drug Co., Inc.: Service Benchmarking
Table 107 Walgreens Boots Alliance, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Walgreens Boots Alliance, Inc.: Service Benchmarking
Table 109 Walgreens Boots Alliance, Inc.: Strategic Outlook

List of Figures
Figure 1 Pharma Wholesale and Distribution Market Segmentation
Figure 2 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
Figure 3 Pharma Wholesale and Distribution Market by Distribution Type: Market Attractiveness Index
Figure 4 Pharma Wholesale and Distribution Market by Product Type: Market Attractiveness Index
Figure 5 Pharma Wholesale and Distribution Market Attractiveness Index by Region
Figure 6 Pharma Wholesale and Distribution Market: Market Dynamics
Figure 7 Pharma Wholesale and Distribution Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 8 Pharma Wholesale and Distribution Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 9 Pharma Wholesale and Distribution Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 10 Pharma Wholesale and Distribution Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 11 Pharma Wholesale and Distribution Market: Porter’s Five Forces Analysis
Figure 12 Pharma Wholesale and Distribution Market: PEST Analysis
Figure 13 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
Figure 14 Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 15 Pharma Wholesale and Distribution Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 16 Wholesalers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 17 Wholesalers Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 18 Producer Wholesaler Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 19 Producer Wholesaler Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 Merchant Wholesaler Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 21 Merchant Wholesaler Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Agents and Brokers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 23 Agents and Brokers Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 25 Distributor Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Single Party Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 27 Single Party Distributor Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 28 Multi Party Distributor Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 29 Multi Party Distributor Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 30 Pharma Wholesale and Distribution Market by Distribution Type: Market Attractiveness Index
Figure 31 Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 32 Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024, 2029, 2034 (%)
Figure 33 Ethical/Branded Pharma Products Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 34 Ethical/Branded Pharma Products Distributors Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 35 Generic Pharma Products Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 36 Generic Pharma Products Distributors Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 37 Propaganda Cum Distribution (PCD) Franchise Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 38 Propaganda Cum Distribution (PCD) Franchise Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 OTC/Institutional Supply Pharma Distributors Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 40 OTC/Institutional Supply Pharma Distributors Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 41 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 42 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Pharma Wholesale and Distribution Market by Product Type: Market Attractiveness Index
Figure 44 Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 45 Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024, 2029, 2034 (%)
Figure 46 Branded Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 47 Branded Pharmaceuticals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 48 Generic Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 49 Generic Pharmaceuticals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Over-the-counter (OTC) Pharmaceuticals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 51 Over-the-counter (OTC) Pharmaceuticals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 Medical Devices Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 53 Medical Devices Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Vaccines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 55 Vaccines Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 56 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 57 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 58 Pharma Wholesale and Distribution Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
Figure 59 Pharma Wholesale and Distribution Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 60 Pharma Wholesale and Distribution Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 61 North America Pharma Wholesale and Distribution Market Attractiveness Index
Figure 62 North America Pharma Wholesale and Distribution Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 63 North America Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 64 North America Pharma Wholesale and Distribution Market Share Forecast by Country, 2024 & 2034 (%)
Figure 65 North America Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 66 North America Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 67 North America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 68 North America Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024 & 2034 (%)
Figure 69 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 70 North America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 71 U.S. Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 72 Canada Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 73 Europe Pharma Wholesale and Distribution Market Attractiveness Index
Figure 74 Europe Pharma Wholesale and Distribution Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 75 Europe Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 76 Europe Pharma Wholesale and Distribution Market Share Forecast by Country, 2024 & 2034 (%)
Figure 77 Europe Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 78 Europe Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 79 Europe Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 80 Europe Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024 & 2034 (%)
Figure 81 Europe Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR.%)
Figure 82 Europe Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 83 Germany Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 84 France Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 85 UK Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 86 Italy Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 87 Spain Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 88 Russia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 89 Rest of Europe Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 90 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
Figure 91 Asia Pacific Pharma Wholesale and Distribution Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 92 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 93 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Country, 2024 & 2034 (%)
Figure 94 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 95 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 96 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 97 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024 & 2034 (%)
Figure 98 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 99 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 100 Japan Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 101 China Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 102 India Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 103 Australia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 104 South Korea Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 105 Singapore Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 106 Rest of Asia Pacific Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 107 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
Figure 108 Latin America Pharma Wholesale and Distribution Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 109 Latin America Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 110 Latin America Pharma Wholesale and Distribution Market Share Forecast by Country, 2024 & 2034 (%)
Figure 111 Latin America Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 112 Latin America Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 113 Latin America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 114 Latin America Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024 & 2034 (%)
Figure 115 Latin America Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 116 Latin America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 117 Brazil Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 118 Mexico Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 119 Argentina Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 120 Colombia Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 121 Rest of Latin America Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 122 MEA Pharma Wholesale and Distribution Market Attractiveness Index
Figure 123 MEA Pharma Wholesale and Distribution Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 124 MEA Pharma Wholesale and Distribution Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 125 MEA Pharma Wholesale and Distribution Market Share Forecast by Country, 2024 & 2034 (%)
Figure 126 MEA Pharma Wholesale and Distribution Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 127 MEA Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 128 MEA Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2024-2034 (US$ Billion, AGR %)
Figure 129 MEA Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2024 & 2034 (%)
Figure 130 MEA Pharma Wholesale and Distribution Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 131 MEA Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 132 GCC Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 133 South Africa Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 134 Rest of MEA Pharma Wholesale and Distribution Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 135 Pharma Wholesale and Distribution Market: Company Share/Ranking, 2022
Figure 136 AmerisourceBergen Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 137 AmerisourceBergen Corporation: Regional Market Shares, 2022
Figure 138 Cardinal Health, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 139 Cardinal Health, Inc.: Regional Market Shares, 2022
Figure 140 Mckesson Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 141 Mckesson Corporation: Regional Market Shares, 2022
Figure 142 Medipal Holdings Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 143 Sinopharm Group Co. Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 144 Walgreens Boots Alliance, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)